A Clinical Study on the Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of SHR-1819 Injection in Patients With Seasonal Allergic Rhinitis

PHASE2RecruitingINTERVENTIONAL

Enrollment

100

Participants

Timeline

Start Date

August 6, 2025

Primary Completion Date

October 31, 2025

Study Completion Date

December 31, 2025

Conditions

Seasonal Allergic Rhinitis

Interventions

DRUG

SHR-1819 Injection

SHR-1819 injection.

DRUG

SHR-1819 Injection Placebo

SHR-1819 injection placebo.

Trial Locations (1)

RECRUITING

Beijing Tongren Hospital, Capital Medical University, Beijing

All Listed Sponsors

lead

Guangdong Hengrui Pharmaceutical Co., Ltd

INDUSTRY